H3 relaxin mediated neuroprotection in Alzheimer’s disease pathology induced by streptozotocin in mouse models: Impact on memory improvement, autophagy and PI3K/Akt-mTOR signalling pathway Cover

.blurhash-client-img { display: none !important; }

H3 relaxin mediated neuroprotection in Alzheimer’s disease pathology induced by streptozotocin in mouse models: Impact on memory improvement, autophagy and PI3K/Akt-mTOR signalling pathway

Acta Pharmaceutica

Volume 76 (2026): Issue 1 (March 2026)

By: Huiyu Zhao, Yuhong Sun, Shaik Althaf Hussain and Hua Gao

Open Access

|Mar 2026

Authors

Huiyu Zhao

Department of Neurology, Harbin, China

Yuhong Sun

Department of Regular Physical Examination Center, Shandong Public Health Clinical Center Shandong University, Jinan, China

Shaik Althaf Hussain

Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia

Hua Gao

g_hua2003@outlook.com

Department of Neurology, Shaanxi Aerospace Hospital, Xi’an, China

DOI: https://doi.org/10.2478/acph-2026-0009 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 1 - 18

Accepted on: Mar 6, 2026

|

Published on: Mar 25, 2026

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Alzheimer’s disease,

streptozotocin,

neuro-protection,

memory improvement

Related subjects:

Pharmacy, other

© 2026 Huiyu Zhao, Yuhong Sun, Shaik Althaf Hussain, Hua Gao, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 76 (2026): Issue 1 (March 2026)